Salarius Pharmaceuticals, Inc.

Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.

SLRX | NDAQ

Overview

Corporate Details

ISIN(s):: US79400X4043 (+1 more)
LEI:
Country:: United States of America
Address:: 2450 HOLCOMBE BLVD, 77021 HOUSTON
Website:: https://salariuspharma.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for patients with cancer and other diseases with high unmet medical needs. The company's technology aims to correct the dysregulated gene expression that drives disease progression. Its pipeline is built on two primary drug classes: targeted protein inhibitors (TPIs) and targeted protein degraders (TPDs). The lead TPI candidate, seclidemstat (SP-2577), is in Phase 1/2 clinical trials for solid and hematologic cancers like leukemias and lymphomas. The company's TPD candidate, SP-3164, is in IND-enabling studies. Following a merger with Decoy Therapeutics, Salarius is also advancing peptide therapeutics for cancer and respiratory viruses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Salarius Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Salarius Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Salarius Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
GMO Research & AI, Inc. Market research tech providing access to 65M+ APAC consumer panelists for data-driven insights.	Japan	3695
GRAIL, Inc. A biotech company that detects multiple cancers early with a single blood test.	United States of America	GRAL
Greatland Resources Limited A gold and copper producer operating and developing mines in Western Australia's Paterson region.	Australia	GGP
Groupe CRIT International provider of human resources, airport assistance, and industrial services.	France	CEN
Gubra A/S CRO & biotech accelerating peptide drug discovery for metabolic and fibrotic diseases.	Denmark	GUBRA
HACKETT GROUP, INC. IP-based strategic advisory on Gen AI and digital transformation for global enterprises.	United States of America	HCKT
HALOZYME THERAPEUTICS, INC. Licenses a drug delivery platform to biopharma, converting IV drugs to subcutaneous injections.	United States of America	HALO
HANATOUR JAPAN CO.,LTD. B2C/B2B travel firm providing packages, MICE, and inbound services, with a focus on Korea.	Japan	6561
HANATOUR SERVICE INC. South Korea's top travel firm offering package tours and custom trips for B2C & B2B clients.	South Korea	039130
Hanmi Science Co.,Ltd A holding company managing R&D-focused pharmaceutical, API, and medical device firms.	South Korea	008930